跳至主要内容
临床试验/IRCT2016122231450N2
IRCT2016122231450N2已完成未知

Intraoperative Mitomycin C Versus Bevacizumab-methycelluse-mixture in Combined Phacoemulsification and Non Penetrating Deep Sclerectomy on Intraocular pressure in patients suffering from open angle glaucoma

Vice Chancellor for research of Tabriz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • The need for cataract surgery in patients with open-angle glaucoma that have glaucomatous progressive cupping and deterioration of the visual field; Diagnosis of open-angle glaucoma on maximally tolerated medical therapy with uncontrolled IOP; The need for cataract surgery in patients with open-angle glaucoma requiring multiple medications to control IOP; Patients suffering from glaucoma and cataract with impaired vision; Patients’ willingness to participate in the study.
  • Exclusion criteria: Patients with contraindications to bevacizumab such as arterial thromboembolic events, uncontrolled hypertension, and congestive heart failure,..; Discernable congenital abnormality of the anterior chamber angle; Ocular infection; Previous ocular surgery; Uveitis; Corneal diseases that could affect IOP or its measurement such as corneal opacity, large pterygium, ...; Patients who are less than 40 years? Diabetes; Neovascular glaucoma? Patient with any systemic or ocular complication.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Tabriz University of Medical Sciences

相似试验

Compare Mitomycin C with Bevacizumab-methycelluse... | 临床试验